Wearable Devices and Biomarkers Project (Healthiomics)

Launched by CURESCIENCE · Oct 24, 2021

Keywords

ClinConnect Summary

The Wearable Devices and Biomarkers Project, also known as Healthiomics, is a clinical trial aimed at improving the care of patients with brain cancer, neurological disorders, or related conditions. The main goal of this study is to collect various types of health information and biological samples, such as blood and urine, from participants. Researchers will use this information to better understand these conditions and develop personalized treatments that could benefit patients in the future.

To participate in this study, you need to be at least 18 years old and have an appointment with oncology or neuroscience services at the participating facility. You could be someone currently dealing with cancer, a neurological disorder, or even someone who is healthy and serving as a control for comparison. All participants will be asked to provide consent to share their health information and samples. If you join the trial, you will help researchers uncover important insights that could lead to better treatments and outcomes for patients with these serious conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participant or participant's legally authorized representative has the ability to understand and the willingness to provide a signed and dated informed consent form.
• • Participant is ≥ 18 years of age.
• • Participant had/has a scheduled appointment with oncology or neurosciences services at the participating medical and surgical facility.
• * Participant is characterized by at least one of the following criteria:
• • 1. Has a neurological complication from any type of cancer, or is under evaluation for a possible cancer diagnosis or neurologic complication. Participant may be newly diagnosed, in relapse, or be free of disease at the time of recruitment. Participant without a confirmed cancer diagnosis is eligible.; OR
• • 2. Has a neurological disorder, or is under evaluation for a possible diagnosis of a neurological disorder; OR
• • 3. Does not meet the characteristic of either a. or b. above. This participant would be considered a "healthy control" for cancer and neurological disorders.
• Exclusion Criteria:
• • Participant or participant's legally authorized representative is unable to provide informed consent.